Antibodies Specific for Claudin 6 (CLDN6)
The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing Claudin-6 (CLDN6), including tumor-related diseases such as ovarian cancer, lung cancer, gastric cancer, breast cancer, hepatic cancer, pancreatic cancer, skin cancer, malignant melanoma, head and neck cancer, sarcoma, bile duct cancer, cancer of the urinary bladder, kidney cancer, colon cancer, placental choriocarcinoma, cervical cancer, testicular cancer, and uterine cancer.
US 2,011,057,788 [MORE INFO
SAHIN UGUR [DE]; TUERECI OEZLEM [DE]; KOSLOWSKI MICHAEL [DE]; WALTER KORDEN [DE]; WOELL STEFAN [DE]; KREUZBERG MARIA [DE]; HUB
Type of Offer:
« More Healthcare Patents« More Medical Patents